HIV vaccine trial ready to roll in Thailand
Licensed archive · Attributed source reporting
411 Brief
With first world countries such as Canada reluctant to engage in trials of a vaccine for HIV, Thailand has completed recruitment of volunteers for Phase III of a clinical trial. Over sixteen thousand selected volunteers from a pool of 65,000 will receive the experimental vaccine combination, ALVAC and AIDS Vac. The trial is concentrated in the provinces of Chon Buri and Rayong and will be monitored over a period of three years to assess the effectiveness of the experimental vaccination. In Canada questions were raised regarding the safety of
With first world countries such as Canada reluctant to engage in trials of a vaccine for HIV, Thailand has completed recruitment of volunteers for Phase III of a clinical trial. Over sixteen thousand selected volunteers from a pool of 65,000 will receive the experimental vaccine combination, ALVAC and AIDS Vac.
The trial is concentrated in the provinces of Chon Buri and Rayong and will be monitored over a period of three years to assess the effectiveness of the experimental vaccination.
In Canada questions were raised regarding the safety of conducting wide-scale trials of a vaccine. It was strongly suspected that participants in a trial might be encouraged to engage in unsafe behaviour when, due to the double-blind nature of the clinical trial, they may have received a placebo in place of the vaccine.
Sources & reporting note
Licensed archive reporting by Wikinews contributors. Text: CC BY 2.5 (https://creativecommons.org/licenses/by/2.5/). Original source date retained. 411 has not independently verified this archive report.
Read the source: Wikinews ↗Source published 22 Dec 2005, 05:30 am IST
